DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20202556

Diffusion tensor imaging in assessment of demyelinating diseases of central nervous system

Arindam Mukherjee, Umesh Chandra Garga

Abstract


Background: Conventional MR plays an important role in detection of demyelinating lesions. Involvement of the lesion core, perilesional region and normally appearing white matter (NAWM) cannot be quantified using routine T2/FLAIR sequences. DTI is an important tool in assessment of anisotropy in affected and apparently normal region of brain. 3D Tractography maps are useful in showing white matter fibre loss. Aim was the assessment of white matter damage and neuroaxonal loss using DTI in demyelinating lesions

Methods: Cross sectional observational study including clinically suspected 30 patients of demyelinating disease. Patients were studied in 3Tesla Siemens Skyra MRI scanner with phased array coils. T1w, T2w, FLAIR, DWI, DTI, post contrast T1w images were included and FA, ADC, Tractography maps were generated. ANOVA test and BONFERONI analysis were used.

Results: We found mean FA of core lesion was 0.307±0.06, of perilesional region 0.444±0.03 and NAWM 0.567±0.06. The mean ADC value of core of the lesion was 1.24×10-3mm2/sec±0.11×10-3mm2/sec, perilesional region 1.16×10-6mm2/sec ±0.1×10-3mm2/sec and NAWM 1.04×10-3mm2/sec±0.06×10-3mm2/sec.

Conclusions: DTI is a useful MR technique that allows quantification of extent of demyelination in the white matter measuring FA and ADC values. The FA values which denote diffusivity and directionality are more reliable marker of demyelination compared to ADC values. DTI Tractography shows white matter tract disruption which may play role in assessing clinical outcome of patients.


Keywords


Apparent diffusion coefficient, Diffusion tensor imaging, Fractional anisotropy, Normally appearing white matter

Full Text:

PDF

References


Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison’s Principles of Internal Medicine, 18th Edition. McGraw Hill Professional; 2011:4322.

Love S. Demyelinating diseases. J Clin Pathol. 2006 Nov;59(11):1151-9.

Ryan M, Ibrahim M, Parmar HA. Secondary demyelination disorders and destruction of white matter. Radiol Clin North Am. 2014;52(2):337-54.

McKeever PE. Chapter 20 - Immunohistology of the Nervous System. In: Dabbs DJ, editor. Diagnostic Immunohistochemistry. 3rd edition. Philadelphia: W.B. Saunders; 2010:820-889.

Osborn AG. Osborn’s Brain: Imaging, Pathology, and Anatomy. Amirsys; 2013:1272.

Sbardella E, Tona F, Petsas N, Pantano P. DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications. Multiple Sclerosis International. 2013

Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiol. 1986 Nov;161(2):401-7.

Fox RJ. Picturing multiple sclerosis: Conventional and diffusion tensor imaging. Semin Neurol. 2008 Sep 1;28(4):453-66.

Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiol. 1996 Dec 1;201(3):637-48.

Kolasinski J, Stagg CJ, Chance SA, DeLuca GC, Esiri MM, Chang EH, et al. A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain. 2012 Oct 1;135(10):2938-51.

Schmierer K, Wheeler-Kingshott CAM, Boulby PA, Scaravilli F, Altmann DR, Barker GJ, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuro Image. 2007;35(2):467-77.

Mukherjee P, Miller JH, Shimony JS, Conturo TE, Lee BCP, Almli CR, et al. Normal Brain Maturation during Childhood: Developmental Trends Characterized with Diffusion-Tensor MR Imaging. Radiol. 2001 Nov 1;221(2):349-58.

Werring DJ, Brassat D, Droogan AG, Clark CA, Symms MR, Barker GJ, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain J Neurol. 2000 Aug;123 ( Pt 8):1667-76.

Guo AC, MacFall JR, Provenzale JM. Multiple Sclerosis: Diffusion Tensor MR Imaging for Evaluation of Normal-appearing White Matter. Radiol. 2002 Mar 1;222(3):729-36.

Temel Ş, Kekliğkoğlu HD, Vural G, Deniz O, Ercan K. Diffusion Tensor Magnetic Resonance Imaging in Patients with Multiple Sclerosis and its Relationship with Disability. Neuroradiol J. 2013 Feb;26(1):3-17.

Tievsky AL, Ptak T, Farkas J. Investigation of Apparent Diffusion Coefficient and Diffusion Tensor Anisotropy in Acute and Chronic Multiple Sclerosis Lesions. Am J Neuroradiol. 1999 Sep 1;20(8):1491-9.

Bammer R, Augustin M, Strasser-Fuchs S, Seifert T, Kapeller P, Stollberger R, et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med. 2000 Oct 1;44(4):583-91.

Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol. 1997 Mar;41(3):385-91.

McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol. 1992 Aug 1;18(4):319-34.

Waxman SG. Demyelinating diseases--new pathological insights, new therapeutic targets. N Engl J Med. 1998 Jan 29;338(5):323-5.

Arnold DL, Matthews PM, Francis GS, O’Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992 Mar;31(3):235-41.

Bozzali M, Cercignani M, Sormani MP, Comi G, Filippi M. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol. 2002 Jul;23(6):985-8.

Castriota Scanderbeg A, Tomaiuolo F, Sabatini U, Nocentini U, Grasso MG, Caltagirone C. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. AJNR Am J Neuroradiol. 2000 May;21(5):862-8.

Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurol. 2001;56(3):304-11.

Qian W, Chan Q, Mak H, Zhang Z, Anthony MP, Yau KKW, et al. Quantitative assessment of the cervical spinal cord damage in neuromyelitis optica using diffusion tensor imaging at 3 Tesla. J Magn Reson Imaging JMRI. 2011 Jun;33(6):1312-20.

Chen J, Zhu L, Li H, Lu Z, Chen X, Fang S. Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis. Exp Ther Med. 2016 Oct;12(4):2505-10.

Balasubramanya KS, Kovoor JME, Jayakumar PN, Ravishankar S, Kamble RB, Panicker J, et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiol. 2007 Feb;49(2):177-83.

Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract. 1993 Mar;189(2):163-73.

Gössl C, Fahrmeir L, Pütz B, Auer LM, Auer DP. Fibre Tracking from DTI Using Linear State Space Models: Detectability of the Pyramidal Tract. Neuro Image. 2002 Jun 1;16(2):378-88.

Conturo TE, Lori NF, Cull TS, Akbudak E, Snyder AZ, Shimony JS, et al. Tracking neuronal fibre pathways in the living human brain. Proc Natl Acad Sci. 1999 Aug 31;96(18):10422-7.

Berman JI, Berger MS, Mukherjee P, Henry RG. Diffusion-tensor imaging—guided tracking of fibres of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas. J Neurosurg. 2004 Jul 1;101(1):66-72.

Mori S, Crain BJ, Chacko VP, Zijl PCMV. Three‐dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol. 1999 Feb 1;45(2):265-9.